JOURNAL OF RHEUMATOLOGY

Scope & Guideline

Empowering Research, Transforming Patient Care

Introduction

Welcome to your portal for understanding JOURNAL OF RHEUMATOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0315-162x
PublisherJ RHEUMATOL PUBL CO
Support Open AccessNo
CountryCanada
TypeJournal
Convergefrom 1974 to 2024
AbbreviationJ RHEUMATOL / J. Rheumatol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA

Aims and Scopes

The Journal of Rheumatology focuses on advancing the understanding and treatment of rheumatic diseases through comprehensive research and clinical studies. It serves as a platform for sharing innovative findings and methodologies related to various aspects of rheumatology.
  1. Autoimmune Disease Mechanisms:
    The journal extensively covers the underlying mechanisms of autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, and other related conditions, emphasizing pathophysiological insights.
  2. Clinical Management and Treatment:
    It focuses on clinical studies that assess the efficacy and safety of various treatment modalities, including biologics, DMARDs, and novel therapeutic strategies for rheumatic diseases.
  3. Diagnostic Innovations:
    The journal highlights advancements in diagnostic techniques, including imaging and laboratory tests, that improve the identification and management of rheumatic conditions.
  4. Comorbidities and Systemic Implications:
    Research on the intersection of rheumatic diseases with other systemic conditions, such as cardiovascular disease and metabolic disorders, is a key focus area, reflecting the comprehensive nature of rheumatology.
  5. Patient-Centric Research:
    There is a consistent emphasis on patient-reported outcomes, quality of life, and psychosocial aspects of living with rheumatic diseases, which are vital for holistic management.
  6. Epidemiological Studies:
    The journal publishes epidemiological research that helps understand the incidence, prevalence, and risk factors associated with various rheumatic diseases.
The Journal of Rheumatology has witnessed a dynamic evolution in its research themes, reflecting emerging trends and areas of increasing importance. This section outlines these trending and emerging scopes that are shaping the future of rheumatology research.
  1. Impact of COVID-19 on Rheumatic Diseases:
    Research examining the effects of COVID-19 on patients with rheumatic diseases has surged, highlighting the need to understand how viral infections influence autoimmune conditions and treatment outcomes.
  2. Biologics and Targeted Therapies:
    There is a growing trend towards studies that investigate the efficacy and safety of biologic agents and targeted therapies, reflecting the shift in treatment paradigms for rheumatic diseases.
  3. Metabolomics and Biomarkers:
    Emerging research on metabolomic profiles and biomarkers is gaining traction, with studies aiming to identify novel diagnostic and prognostic indicators for rheumatic diseases.
  4. Psychosocial Factors and Quality of Life:
    An increasing number of publications focus on the psychosocial aspects of rheumatic diseases, including mental health, quality of life, and patient education, emphasizing a holistic approach to patient care.
  5. Multidisciplinary Approaches:
    The journal is seeing more interdisciplinary studies that incorporate perspectives from various fields such as immunology, cardiology, and neurology, reflecting the complex nature of rheumatic diseases.

Declining or Waning

While the Journal of Rheumatology continues to grow in many areas, certain themes within its scope appear to be declining in prominence. This section highlights these waning themes that may reflect shifts in research focus or clinical relevance.
  1. Traditional Pharmacotherapy:
    There is a noticeable decline in publications focusing solely on traditional pharmacological treatments for rheumatic diseases, as the field shifts towards biologics and targeted therapies.
  2. Basic Science Research:
    Papers that delve exclusively into basic science without clinical implications have become less frequent, indicating a trend towards more clinically relevant research.
  3. Historical Case Reports:
    The frequency of case reports detailing rare or historical presentations of rheumatic diseases has diminished, possibly due to a preference for larger cohort studies and systematic reviews.
  4. Single-Center Studies:
    There is a reduced emphasis on single-center studies, as multi-center and collaborative research efforts gain traction, reflecting a movement towards more robust and generalizable findings.
  5. Non-Pharmaceutical Interventions:
    Research on non-pharmaceutical interventions, such as lifestyle modifications and alternative therapies, has seen a decline, possibly overshadowed by the growing interest in biologic therapies.

Similar Journals

RMD Open

Advancing knowledge in Immunology and Rheumatology.
Publisher: BMJ PUBLISHING GROUPISSN: 2056-5933Frequency: 2 issues/year

RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.

International Journal of Rheumatology

Leading the way in rheumatic disease advancements.
Publisher: HINDAWI LTDISSN: 1687-9260Frequency: 1 issue/year

The International Journal of Rheumatology, published by HINDAWI LTD, serves as a vital resource for researchers and practitioners in the fields of rheumatology and immunology. Since its inception in 2009 as an Open Access journal, it has aimed to disseminate high-quality, peer-reviewed research to foster advancements in the understanding and treatment of rheumatic diseases. With an ISSN of 1687-9260 and E-ISSN of 1687-9279, the journal has become increasingly relevant, achieving a respectable Q3 ranking in both the Immunology and Rheumatology categories in 2023, and earning a Scopus rank of #27 out of 73 in Medicine Rheumatology. The journal's commitment to excellence is reflected in its wide-ranging scope, addressing current trends and innovations through empirical studies, reviews, and clinical insights. Its global readership, based in the United States and beyond, highlights the journal's importance in shaping the discourse within rheumatological research. As it converges through the years from 2010 to 2024, the International Journal of Rheumatology continues to be a cornerstone for sharing groundbreaking findings and fostering collaboration in the rheumatic disease community.

European Journal of Rheumatology

Exploring Innovations in Rheumatic Disease Treatment
Publisher: AVESISSN: 2147-9720Frequency: 4 issues/year

European Journal of Rheumatology is a premier, peer-reviewed journal that has been paving the way for innovative research and in-depth analysis in the field of rheumatology since its launch. Published by AVES, this Open Access journal has been accessible to researchers, professionals, and students worldwide since 2014, promoting the sharing of valuable knowledge on rheumatic diseases and their treatment. With an ISSN of 2147-9720 and an E-ISSN of 2148-4279, it provides a prominent platform for groundbreaking studies and clinical evaluations that bridge scientific discovery with practical application. The journal’s mission is to enhance the understanding of rheumatological conditions and facilitate advancements in therapeutic strategies, making it an essential resource for anyone devoted to the improvement of patient care in this dynamic field. The European Journal of Rheumatology is committed to upholding the highest standards of scholarly publishing and aims to foster collaboration among researchers and practitioners across Europe and beyond.

Open Access Rheumatology-Research and Reviews

Empowering Researchers with Open Access Insights.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

Reumatologia Clinica

Exploring breakthroughs in clinical rheumatology.
Publisher: ELSEVIER ESPANA SLUISSN: 1699-258XFrequency: 6 issues/year

Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders

Enhancing patient care with groundbreaking research.
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5441Frequency: 1 issue/year

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders, published by SAGE PUBLICATIONS LTD, is an esteemed open-access journal dedicated to advancing knowledge in the field of rheumatology and related immunological disorders. Since its inception in 2008, the journal has provided a platform for researchers and clinicians from around the world to disseminate cutting-edge studies and insights into arthritis and musculoskeletal conditions. Based in New Zealand, this journal has maintained a commendable standing in academic circles, evidenced by its Q3 quartile rankings in both Immunology and Allergy and Rheumatology categories for 2023, alongside respectable Scopus rankings. The journal serves as a vital resource for healthcare professionals, researchers, and students, facilitating enhanced understanding and treatment of musculoskeletal disorders through high-quality research and peer-reviewed articles. With a focus on fostering interdisciplinary collaboration and innovation in the field, Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders is essential reading for those committed to improving patient outcomes and advancing scientific knowledge.

BMC Rheumatology

Fostering dialogue and discovery in rheumatic diseases.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Fostering innovation for better patient outcomes.
Publisher: CLINICAL & EXPER RHEUMATOLOGYISSN: 0392-856XFrequency: 6 issues/year

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.

SEMINARS IN ARTHRITIS AND RHEUMATISM

Unveiling the latest in arthritis and pain medicine.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

Archives of Rheumatology

Pioneering research for better patient outcomes in rheumatology.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.